Achieve Life Sciences Inc (ACHV.OQ)
ACHV.OQ on NASDAQ Stock Exchange Capital Market
9.16USD
25 Sep 2020
9.16USD
25 Sep 2020
Change (% chg)
$0.52 (+6.02%)
$0.52 (+6.02%)
Prev Close
$8.64
$8.64
Open
$8.60
$8.60
Day's High
$9.27
$9.27
Day's Low
$8.39
$8.39
Volume
23,332
23,332
Avg. Vol
85,373
85,373
52-wk High
$44.20
$44.20
52-wk Low
$4.60
$4.60
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -1.32 | December | 26 Sep 2020 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 1 | 1 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 0 | 0 | 0 | 0 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.67 | 1.67 | 1.67 | 1.67 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-20 | 2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-20 | 2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-20 | 2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-21 | 2 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-20 | 2 | -1.32 | -1.30 | -1.33 | -0.37 |
| Quarter Ending Dec-20 | 2 | -2.38 | -2.23 | -2.54 | -0.57 |
| Year Ending Dec-20 | 2 | -7.57 | -7.32 | -7.82 | -1.48 |
| Year Ending Dec-21 | 2 | -6.59 | -5.94 | -7.25 | -0.77 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Jun-20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Mar-20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | ||||
| Quarter Ending Jun-20 | -0.12 | -1.68 | 1.56 | -1,262.53 |
| Quarter Ending Mar-20 | -0.12 | -0.11 | 0.01 | -8.33 |
| Quarter Ending Dec-19 | -0.32 | -0.30 | 0.02 | -6.25 |
| Quarter Ending Sep-19 | -0.30 | -0.45 | 0.15 | -48.37 |
| Quarter Ending Jun-19 | -0.56 | -0.50 | 0.06 | -10.71 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-21 | 0.00 | 0.00 | 0.00 | 18.75 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Sep-20 | -1.32 | -1.32 | -1.32 | -0.13 | -0.37 |
| Quarter Ending Dec-20 | -2.38 | -2.38 | -2.38 | -0.14 | -0.57 |
| Year Ending Dec-20 | -7.57 | -7.57 | -7.57 | -0.49 | -1.48 |
| Year Ending Dec-21 | -6.59 | -6.59 | -6.59 | -0.22 | -0.77 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-20 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-20 | 0 | 0 | 0 | 0 |
| Year Ending Dec-20 | 0 | 0 | 0 | 0 |
| Year Ending Dec-21 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Sep-20 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-20 | 0 | 0 | 0 | 0 |
| Year Ending Dec-20 | 0 | 0 | 0 | 0 |
| Year Ending Dec-21 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- BRIEF-Achieve Life Sciences Reports Pricing Of $6 Mln Registered Direct Offering
- BRIEF-Achieve Life Sciences Files Prospectus Related To Registration For Potential Offer, Sale Of Upto 10.3 Mln Shares By Selling Stockholders
- BRIEF-Achieve Life Sciences Reports Qtrly Loss Per Share $0.11
- BRIEF-Achieve Life Sciences Reports Qtrly Loss Per Share $0.11